Accreditation Information

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activityfor a maximum of 1.5 AMA PRA Category 1.5 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives

1. Explain the complex symptoms of Amyloidosis
2. Facilitate multidisciplinary care for patients with amyloidosis disease
3. Screen amyloidosis patients for clinical trials
4. Discuss current amyloidosis research

Target Audience

The amyloidosis center clinical team members (includes hephrology, hematology, neurology, pulmonary, cardiology and internal medicine) as well as their respective fellows and residents.

Faculty Disclosure

Faculty, Planning Committee and CME Administrator disclosure statement:

Vaishali Sanchorawala, Speaker, Course Director and Planning Committee, receives grant from Caelum, and receives research support from Takeda, Janssen, Prothena, and Celgene. 

John Berk, Speaker, Co-Course Director and Planning Committee, receives travel support from Alnylam Pharmaceuticals, and is an ad hoc advisory honorarium for Ionis Pharmaceutical

Shayna Sarosiek,  Co-Course Director, has no relevant financial relationships to disclose.

Sakina Flint, RSS Coordinator, has no relevant financial relationships to disclose.

 

Faculty disclosure of off-label use:

Vaishali Sanchorawala does not plan on discussing unlabeled/investigational uses of a commercial product.

John Berk does plan on discussing unlabeled/investigational uses of a commercial product.

Shayna Sarosiek does plan on discussing unlabeled/investigational uses of a commercial product.

Sakina Flint does not plan on discussing unlabeled/investigational uses of a commercial product.

Faculty disclosure policy:

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.